Final answer:
In a client with systemic lupus erythematosus on corticosteroid therapy, the nurse should assess for skeletal muscle atrophy and osteoporosis, as well as hyperglycemia and fluid retention, which are common side effects of prolonged corticosteroid use.
Step-by-step explanation:
A client with systemic lupus erythematosus (SLE) who has been on corticosteroid therapy should be assessed for various potential side effects of prolonged corticosteroid use. When evaluating which assessments to make, it is important to consider common adverse effects of steroids and compare them to the symptomatology of SLE.
- B. Skeletal muscle atrophy and osteoporosis: Chronic use of corticosteroids can lead to muscle weakness and reduction in bone mineral density, predisposing a patient to osteoporosis.
- E. Hyperglycemia and fluid retention: Corticosteroids can cause increased blood sugar levels and fluid retention, which are significant side effects that need monitoring.
Tests for hypoglycemia would typically be inappropriate, as hyperglycemia is the more common effect of corticosteroids. Hyponatremia and hypokalemia are not typical side effects of steroid use in the context of SLE. While hyperpigmentation and itching can occur due to SLE, they are not directly related to corticosteroid therapy. Therefore, options B and E are the correct selections for the nurse to assess in a patient with SLE on long-term corticosteroid therapy.